Real-World Analysis of Clinical and Demographic Characteristics, Treatment Patterns, and Outcomes in Predominantly Older Patients with HR+/HER2− Metastatic Breast Cancer Receiving Abemaciclib in Routine Clinical Practice

• المؤلفون الرئيسيون: Alistair Ring (مؤلف), Meghan Karuturi (مؤلف), Emily Nash Smyth (مؤلف), Tasneem Lokhandwala (مؤلف), Kristin M. Sheffield (مؤلف), Joanne Willey (مؤلف), Orsolya Lunacsek (مؤلف), Francisco Sapunar (مؤلف), Zhanglin Lin Cui (مؤلف), Anna D. Coutinho (مؤلف), Sarah Rybowski (مؤلف)
• التنسيق: كتاب
• منشور في: Adis, Springer Healthcare, 2023-09-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

Abstract Introduction Hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2−) is the most frequently diagnosed metastatic breast cancer (mBC) subtype. Combinations of endocrine therapy (ET) with cyclin-dependent kinase 4/6 inhibitors (CDK4 & 6is) improve outcome...